Evaluating new methods for assessing coronary artery disease after procedures
Official title: Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients
Run by Fundación EPIC · NCT06273293 · Data updated 2026-11-12
This study is testing a new way to check for coronary artery disease in patients with multiple blocked arteries to see if it works better than the usual method after they have heart procedures.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Fundación EPIC Academic / other |
| Locations | 4 sites (Alicante and 3 other locations) |
| Status | Recruiting |
| Started | May 31, 2024 |
| Main results expected | December 20, 2026 |
| Study ends | January 20, 2027 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT06273293 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 with multivessel coronary artery disease requiring percutaneous coronary revascularization.
✕Probably not a fit
Patients with contraindications to adenosine or significant comorbidities limiting life expectancy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of using a new method called cFFR-NTG for assessing coronary artery disease in patients with multivessel conditions. It aims to improve the management of intermediate coronary lesions by comparing this method to the traditional fractional flow reserve (FFR) technique, which often requires adenosine. The study will involve patients undergoing percutaneous coronary intervention (PCI) and will utilize a specialized pressure microcatheter for both diagnosis and post-procedure evaluation. By focusing on patients with significant stenosis in multiple vessels, the trial seeks to enhance therapeutic decision-making and patient outcomes.
Why it matters
Potential benefit: If successful, this approach could lead to better management of coronary artery disease and reduced risk of future cardiovascular events for patients.
How similar studies have gone: Other studies have shown promise with similar approaches, particularly in improving outcomes for patients with coronary artery disease.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \>18 years old and, * Patients with multivessel coronary artery disease (multivessel coronary artery disease will be considered the presence of significant stenosis in 2 or more first or second order vessels greater than 1.5 mm in diameter with an angiographic reduction of their diameter ≥50% by visual estimation) subsidiary of percutaneous coronary revascularization in at least one of them and, * Use of Navvus pressure microcatheter both for functional diagnosis and for post-PCI evaluation of the different vessels and, * Patients who have signed the Informed Consent. Exclusion Criteria: * Patients with intolerance or contraindication to adenosine. * Hemodynamically unstable patients, acute phase of a STEACS. * Patient with significant comorbidity with limited life expectancy. * Patients with the patient's express refusal to participate in the study. * Pregnant or breastfeeding female patients.
Where it's running
-
Hospital Universitario San Juan de Alicante
Alicante, Spain Recruiting -
Hospital Universitario de Badajoz
Badajoz, Spain Recruiting -
Hospital Universitario Juan Ramón Jiménez
Huelva, Spain Recruiting -
Hospital Universitario Virgen del Rocío
Seville, Spain Recruiting
Study contacts
- Study coordinator: SANTIAGO J CAMACHO FREIRE, MD, PhD
- Email: hemodinamica.cardiologia.huelva@gmail.com
- Phone: 0034677981941
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Predicting how coronary artery disease progresses in adults 45 and younger
This project will try to build prediction models using coronary CT scans and health data from people aged 18–45 to see who is more likely to have plaque get worse over time.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
Italian Cardiac Rehabilitation Registry for Coronary Disease and Heart Failure
This registry collects real-world information to see how cardiac rehabilitation programs work for adults recovering from coronary disease or heart failure across Italy.
-
Orbital atherectomy versus standard balloon strategy for calcified coronary bifurcation lesions
This study tests whether using orbital atherectomy before stenting helps adults with moderately or severely calcified coronary bifurcation lesions get better stent results than the standard balloon-first approach.
-
Healthy Nordic diet's effects on heart disease
This study is testing if following a Healthy Nordic diet can help people with coronary heart disease improve their heart health over 18 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.